Evidence map›Paper›PMID 36143697›Full record

ReviewMaterials (Basel, Switzerland)2022

Enzyme-Triggered Crosslinked Hybrid Hydrogels for Bone Tissue Engineering.

Ankur Sood, Seong Min Ji, Anuj Kumar, Sung Soo Han

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Transient Catalase Immobilization for Cytoprotection during HACS biomaterials science & engineering · 2025
    Article
  3. Smart hydrogels for in situ tissue drug delivery.Journal of biomedical science · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. The role of smart polymeric biomaterials in bone regeneration: a review.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ankur SoodSchool of Chemical Engineering, Yeungnam University, 280 Daehak-ro, Gyeongsan 38541, Korea.
Seong Min JiSchool of Chemical Engineering, Yeungnam University, 280 Daehak-ro, Gyeongsan 38541, Korea.
Anuj KumarSchool of Chemical Engineering, Yeungnam University, 280 Daehak-ro, Gyeongsan 38541, Korea.ORCID 0000-0001-6434-875X
Sung Soo HanSchool of Chemical Engineering, Yeungnam University, 280 Daehak-ro, Gyeongsan 38541, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quest to develop state-of-the-art hydrogels for bone tissue engineering has accompanied substantial innovation and significant progression in the field of bioactive hydrogels. Still, there is scope for advancement in this cell-friendly and biocompatible scaffold system. The crosslinking approaches used for hydrogel synthesis plays a decisive role in guiding and regulating the mechanical stability, network framework, macroscopic architect, immunological behaviors, and cellular responses. Until recently, enzyme-based crosslinking strategies were considered as the pinnacle in designing efficient hybrid hydrogel systems. A variety of enzymes have been explored for manufacturing hydrogels while taking the advantage of the biocompatible nature, specificity, ability to produce nontoxic by products and high efficiency of enzymes. The current review focuses on the utility of different enzymes as crosslinking agents for hydrogel formation with their application in bone tissue engineering. The field of enzyme crosslinked hydrogel synthesis is rapidly maturing with a lot of opportunities to be explored in bone tissue engineering. Enzyme-based in situ and externally crosslinked hydrogels for bone regeneration is an attractive field, and with innovation in using engineered enzymes this field will continue to flourish with clinical orientation.

Indexed as

biomaterialsbone tissue engineeringcrosslinkingenzymehydrogelspolymers

Identifiers

PMID36143697
PMCPMC9506111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.